Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Gold Nanoparticles and Ions Exposure on the Aquatic Organisms.
Hlavkova D, Caloudova H, Palikova P, Kopel P, Plhalova L, Beklova M, Havelkova B. Hlavkova D, et al. Bull Environ Contam Toxicol. 2020 Oct;105(4):530-537. doi: 10.1007/s00128-020-02988-6. Epub 2020 Sep 17. Bull Environ Contam Toxicol. 2020. PMID: 32940716
Unusual functions of insect vitellogenins: minireview.
Kodrík D, Čapková Frydrychová R, Hlávková D, Skoková Habuštová O, Štěrbová H. Kodrík D, et al. Among authors: hlavkova d. Physiol Res. 2023 Dec 29;72(S5):S475-S487. doi: 10.33549/physiolres.935221. Physiol Res. 2023. PMID: 38165752 Free PMC article. Review.
Essential Oils: Useful Tools in Storage-Pest Management.
Cagáň Ľ, Apacsová Fusková M, Hlávková D, Skoková Habuštová O. Cagáň Ľ, et al. Among authors: hlavkova d. Plants (Basel). 2022 Nov 13;11(22):3077. doi: 10.3390/plants11223077. Plants (Basel). 2022. PMID: 36432806 Free PMC article.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
16 results